APIXABAN is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting factor Xa.

Products still subject to third-party patent protection might be available solely for R&D purposes.

PRANLUKAST HYDRATE is a cysteinyl leukotriene receptor-1 antagonist. It is widely used in Japan.

Products still subject to third-party patent protection might be available solely for R&D purposes.

SUGAMMADEX SODIUM is a medication for the reversal of neuromuscular blockade induced by rocuronium and vecuronium in general anaesthesia. It is the first selective relaxant binding agent (SRBA).

Products still subject to third-party patent protection might be available solely for R&D purposes.

ROXULITINIB PHOSPHATE is a medication used for the treatment of intermediate or high-risk myelofibrosis.

Products still subject to third-party patent protection might be available solely for R&D purposes.